Essential Science provides expert, hands-on support in business development, partnering and technology exploitation in the Life Sciences, Biotechnology and Drug Discovery and Development Sectors.

Through our client portfolio we are able to offer access to a wide range of technologies focused at providing new opportunities in:

• Drug Discovery
• Technology to improve the immobilization and bio-orientation of small- and macro-molecules in drug screening and other applications
• Proven antibiotic drug discovery engine based on a combination of intelligent design and in-silico and functional screening
• Novel, validated bacterial target and screening assay for the discovery of antibiotics for G-ve and G+ve bacteria


• Protein Therapeutics
• Cotherapy with the potential to enhance the biological and therapeutic efficacy of monoclonal antibodies (Mabs) in oncology
• Technologies for replacing Insulin and L-Glutamine in protein drug development and manufacture using mammalian cell culture
• Technologies for enhancing downstream purification of monoclonal antibodies
• Technology for improving protein conjugation


• In- and Out-Licensing and Collaborative Development Opportunities
• Discovery and development collaboration in small molecule antibiotics
• Development collaboration in protein therapeutics for oncology
• Novel cotherapy opportunity to enhance the efficacy of anti-infective therapies
• Novel biologic and biomaterial combination products for localized therapy
• In-licensing and collaborative development opportunity in secondary manufacture with particular interest in syrups, aerosols, gels and foams